Andrew Radonjic – Managing Director – Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Copyright 2023 – Finance News Network
Source: Finance News Network
30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More28 Aug 2019 - Noxopharm Limited (ASX:NOX) CEO Dr Greg van Wyk discusses the company's anti-prostate cancer drug Veyonda, its efficacy in prostate cancer treatment, the drug’s upside and the company’s strategy for growth.
Read More15 Nov 2022 - OncoSil Medical Limited (ASX:OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy.
Read More25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Dean Tuck, Managing Director of Dreadnought Resources (ASX:DRE).
Read More13 May 2024 - Lithium Universe's CEO Alex Hanly unveils the company's strides in 2024 towards North American lithium independence.
Read More31 Aug 2021 - VRX Silica Limited (ASX:VRX) Managing Director Bruce Maluish provides an update on the company's Arrowsmith and Muchea silica sand projects, potential offtake partners and financing.
Read More19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Read More24 May 2021 - BluGlass Limited (ASX:BLG) Non-Executive Director Jean-Michel Pelaprat talks about joining BluGlass, his experience, and the future for BluGlass's gallium nitride technology.
Read More17 Mar 2025 - LAG-3 and the Role of Immune Checkpoints in Cancer Treatment
Read More21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More
